Rheumatology 2000; 39: 1425-1427
© 2000 British Society for Rheumatology
Letters to the Editor |
The effects of dothiepin on subjects with rheumatoid arthritis and depression
Department of Rheumatology, Dryburn Hospital, North Road, Durham DH1 5TW, UK
| The first 10% of the full text of this article appears below. |
SIR, We read with great interest the paper by Ash et al. [1], and would like to bring to readers' attention our own similar study, presented to the British Society of Rheumatology in 1989 [2].
One hundred and eighty-four patients with rheumatoid arthritis (RA), stable on second-line therapy, were screened for anxiety and depression using the Hospital and Depression scale (HAD); 91% (45%) met the entry requirements (HAD>7 on the subscales or >11 on the combined score), of whom 58 were recruited to receive dothiepin 75 mg or matched placebo for 6 weeks. Exclusions were as in the Ash et al. study, with
Department of Psychiatry, Ormskirk & District General Hospital, Wigan Road, Ormskirk, Lancashire L39 2JW and
1 Department of Psychiatry, University of Manchester, Rawnsley Building, Manchester Royal Infirmary, Oxford Road, Manchester M13, UK